Literature DB >> 32051157

Wound botulism presenting as dysphagia to an ENT ward.

Lucy Qian Li1, Andrew Cadamy2, Andrew Seaton2.   

Abstract

A 44-year-old man with a background of heroin injection drug use was referred to the ear, nose and throat team with a sore throat and dysphagia. He was treated with intravenous antibiotics and steroids for suspected uvulitis. He developed progressive bulbar weakness and symmetrical descending weakness of the upper extremities over a 12-hour period and was intubated prior to transfer to the intensive care unit.Botulinum heptavalent antitoxin was administered, and subsequent PCR assay confirmed Clostridium botulinum neurotoxin B from his most recent injection site. He was found unconscious on the ward 3 days following extubation. Postmortem confirmed he died from heroin intoxication.This case highlights the importance of considering wound botulism in injection drug users presenting with unexplained weakness, particularly of the lower cranial nerves. Botulism is not characteristically associated with signs of localised or systemic infection in contrary to other bacterial complications of injection drug use. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  botulinum toxin; drugs misuse (including addiction); otolaryngology/ENT

Mesh:

Substances:

Year:  2020        PMID: 32051157      PMCID: PMC7021180          DOI: 10.1136/bcr-2019-232367

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Wound botulism in the UK and Ireland.

Authors:  Moira M Brett; Gill Hallas; Obioma Mpamugo
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

Review 2.  Clostridial neurotoxins.

Authors:  A Goonetilleke; J B Harris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 3.  Botulism: the challenge of diagnosis and treatment.

Authors:  Itzhak Brook
Journal:  Rev Neurol Dis       Date:  2006

4.  Wound botulism, its neurological manifestations, treatment and outcomes: A case series from the Glasgow outbreak, 2015.

Authors:  Sarah-Jane Martin; Gillian Penrice; Corinne Amar; Kathie Grant; George H Gorrie
Journal:  Scott Med J       Date:  2017-05-07       Impact factor: 0.729

Review 5.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

Review 6.  Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom.

Authors:  M M Brett; J Hood; J S Brazier; B I Duerden; S J M Hahné
Journal:  Epidemiol Infect       Date:  2005-08       Impact factor: 2.451

7.  Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism.

Authors:  C E Sandrock; S Murin
Journal:  Chest       Date:  2001-08       Impact factor: 9.410

8.  Wound botulism in injection drug users: time to antitoxin correlates with intensive care unit length of stay.

Authors:  Steven R Offerman; Melissa Schaefer; Joseph G Thundiyil; Matthew D Cook; James F Holmes
Journal:  West J Emerg Med       Date:  2009-11

9.  Infections with spore-forming bacteria in persons who inject drugs, 2000-2009.

Authors:  Norah E Palmateer; Vivian D Hope; Kirsty Roy; Andrea Marongiu; Joanne M White; Kathie A Grant; Colin N Ramsay; David J Goldberg; Fortune Ncube
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.